NCT07071909 2026-01-06
Immune Reconstitution Monitoring and Pneumococcal Vaccination in Patients Treated With CAR-T Cells
UNC Lineberger Comprehensive Cancer Center
Phase 1/2 Withdrawn
Clinical Trials
8 trialsNCT05205252 2023-08-15
ARIA
Ipsen
Phase 1/2 Withdrawn
NCT03986086 2020-03-20
MPH966 for Prevention of Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
Duke University
Phase 1/2 Withdrawn
NCT02709993 2019-10-14
Consolidation Therapy in Patients With Hematologic Malignancies
Kiromic BioPharma Inc.
Phase 1/2 Withdrawn
NCT02223312 2018-08-28
Therapy for Progressive and/or Refractory Hematologic Malignancies
Kiromic BioPharma Inc.
Phase 1/2 Withdrawn
NCT01163201 2017-12-02
T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies
Masonic Cancer Center, University of Minnesota
Phase 1/2 Withdrawn
NCT01326273 2015-06-08
Autologous Cytomegalovirus (CMV) Specific CD8+ T Cells as Treatment for CMV Reactivation
Imperial College London
Phase 1/2 Withdrawn
NCT01620229 2014-04-21
Brentuximab Vedotin After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Fred Hutchinson Cancer Center
Phase 1/2 Withdrawn